Donepezil Hydrochloride

Donepezil Hydrochloride (API)

Donepezil hydrochloride is a reversible acetylcholinesterase inhibitor used to manufacture medicines for the symptomatic treatment of Alzheimer’s disease.

Uses of Finished Medicines

• Symptomatic treatment of Alzheimer’s disease as prescribed by a physician

Inhibiting acetylcholinesterase reduces acetylcholine breakdown in the central nervous system and enhances cholinergic transmission.

Product Information

• English name: Donepezil Hydrochloride
• Therapeutic class: Acetylcholinesterase inhibitor
• Common finished dosage form: Tablets
• Known brand names: Aricept

Note: This page describes pharmaceutical raw material for industrial use. It is not medical advice; finished medicines must be used as prescribed by a physician.

Reference Chemical Identity

Identity reference: DailyMed — Donepezil Hydrochloride.

Technical Specifications and Quality Documents

Contact the NEB technical team for specifications, a certificate of analysis (COA), safety data sheet (SDS), packaging and availability. Reference values do not replace approved specifications or the batch-specific certificate of analysis.